Percutaneous Absorption of Sunscreen Filters: Review of Issues and Challenges.


Journal

Current problems in dermatology
ISSN: 1662-2944
Titre abrégé: Curr Probl Dermatol
Pays: Switzerland
ID NLM: 0147371

Informations de publication

Date de publication:
2021
Historique:
entrez: 26 10 2021
pubmed: 27 10 2021
medline: 5 2 2022
Statut: ppublish

Résumé

Although skin is a vital barrier to the outside world, it is permeable to certain substances used in topical pharmacotherapy. It is therefore not surprising that other xenobiotics intentionally or accidentally coming in contact with skin can cross the skin barrier. Long before the turn of the millennium, it became clear that sunscreen filters from sunscreen products can be systemically absorbed and detected in urine and plasma. Against this background, we review issues and challenges with safety assessments related to the possible percutaneous absorption of the sunscreen filters. A reference is made to the Regulation (EC) No. 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (version 1 August 2018) and the concepts of the Maximal Usage Trial (MUsT) and Generally Recognized As Safe and Effective (GRASE), currently discussed in the United States.

Identifiants

pubmed: 34698027
pii: 000517595
doi: 10.1159/000517595
doi:

Substances chimiques

Sunscreening Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

188-202

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Christian Surber (C)

Department of Dermatology, Universitätsspital Zürich, Zurich, Switzerland.
Department of Dermatology, Universitätsspital Basel, Basel, Switzerland.

James Plautz (J)

CHRYSALIS Services AG, Basel, Switzerland.

Myriam Sohn (M)

BASF Grenzach GmbH, Grenzach-Wyhlen, Germany.

Howard I Maibach (HI)

Department of Dermatology, University of California San Francisco, San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH